Top multi-store & online German CBD retail brand open for acquisition
Amazing opportunity to enter the CBD market with one of the top CBD Brands in Germany. Opportunity comprised of two stores, established e-commerce platform, multiple brands, and diversified, natural and organic CBD products
Listing ID:
13313389713
Licence(s) Held:
General Retail License
Seeking outright divestiture of the going concern business for €1 million o.b.o
Listing Details:
A German CBD company focused on retail, wholesale and online sales is offering a wide range of high-quality, organic CBD and hemp products under established brands in the EU market
Products include different types of inflorescences, hashish, hemp/CBD cosmetics, hemp food, capsules and much more
Internationally positioned, includes a well-presented online platform for customers ordering online CBD products
Averaging over €1,000,000 yearly revenue and profit margins range between 54% and 62%
The stores are strategically situated in Berlin for legal cannabis clubs in Germany
Existing supply agreement in place from a specialty ecological agricultural facility
Experienced serial entrepreneurs and leadership team with deep operating experience, strong sale and distribution, logistics team with proven track record
Includes a general retail license that allows to sell vapes, e-liquids, cosmetics and etc
Great potential for a North American cannabis retail operator to acquire this fascinating German CBD retail brand in advance of German adult use cannabis legalization
13313389713
NEW CANNABIS BUSINESSES FOR SALE
See the latest cannabis business listings on the market including dispensaries, cultivation facilities, greenhouses, labs, and more. If you're looking to invest, acquire, or expand, these business opportunities provide the perfect starting point to grow your footprint in the cannabis industry.
36324927098
Licensed Colombian medical cannabis platform targeting EU pharmaceutical market seeks $3M equity partner
Premium, fully licensed Colombian cannabis cultivation platform offering pharmaceutical-grade production at industry-leading costs, with secured European market access and scalable growth potential
29345918591
State-of-the-art, ~130,000 sq. ft. production facility with 20.5 tonnes annual capacity and & EU-GMP designed processing hub
Opportunity to acquire a custom-designed, ~130,000 sq. ft. turnkey production asset including 84,000 square feet of canopy designed for pharmaceutical-grade output. This unique opportunity allows for a clean-slate acquisition of world-class infrastructure providing an immediate entry point into the global medicinal and premium international markets.